Kayne Anderson Rudnick Investment Management’s Apyx Medical APYX Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,000	Closed	-$12.8K	–	963
2023 Q3	$12.8K	Hold	4,000	–	–	﹤0.01%	577
2023 Q2	$20.1K	Hold	4,000	–	–	﹤0.01%	558
2023 Q1	$11.5K	Hold	4,000	–	–	﹤0.01%	558
2022 Q4	$9.36K	Hold	4,000	–	–	﹤0.01%	578
2022 Q3	$18K	Hold	4,000	–	–	﹤0.01%	537
2022 Q2	$23K	Buy	+4,000	New	+$20.5K	﹤0.01%	511

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's APYX Position: Q4 2023 in Review

Kayne Anderson Rudnick Investment Management sold out of Apyx Medical (APYX) in Q4 2023, closing a stake of 4,000 shares — an estimated $12.8K sold.

Kayne Anderson Rudnick Investment Management first reported a position in APYX in Q2 2022 and held it in 6 quarters. The position peaked at $23K in Q2 2022. 62 funds tracked by Wall St. Rank hold APYX as of Q4 2023.

Kayne Anderson Rudnick Investment Management reported no remaining Apyx Medical position as of Q4 2023 after selling out during the quarter.
Kayne Anderson Rudnick Investment Management sold 4,000 Apyx Medical shares in Q4 2023, an estimated $12.8K.
Kayne Anderson Rudnick Investment Management first reported a position in Apyx Medical in Q2 2022 and held it in 6 quarters.
Kayne Anderson Rudnick Investment Management's Apyx Medical position peaked at $23K in Q2 2022.
62 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2023.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.